Mgr. Jan Smetana, Ph.D.
Researcher II, Section of Genetics and Molecular Biology
Office: bldg. C03/333
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 7640 |
---|---|
E‑mail: |
Total number of publications: 86
2010
-
Gain of 1q21 Is an Unfavorable Genetic Prognostic Factor for Multiple Myeloma Patients Treated with High-Dose Chemotherapy
Biology of Blood and Marrow Transplantation, year: 2010, volume: 16, edition: 4
-
Korelace flowcytometrických a cytogenetických nálezů u nově diagnostikovaných pacientů s mnohočetným myelomem
Year: 2010, type: Conference abstract
-
Monoclonal gammopathy of undetermined significance - possibilities of molecular cytogenetic analysis in patients with low percent of bone marow plasma cells infiltration
Year: 2010, type: Conference abstract
-
Monoklonální gamapatie nejasného významu: Možnosti molekulárně cytogenetického vyšetření u osob s nízkou infiltrací kostní dřeně nádorovými plazmocyty
Year: 2010, type: Conference abstract
-
Negative prognostic significance of two or more cytogenetic abnormalities in multiple myeloma patients treated with autologous stem cell transplantation
Neoplasma, year: 2010, volume: 57, edition: 2
-
Oligonucleotide array-based comparative genomic hybridization analyses of gain 1q21 in multiple myeloma
Year: 2010, type: Conference abstract
-
Prognostic and predictive impact of cytogenetic changes in relapsed multiple myeloma patients treated with bortezomib or thalidomid based regiments: a Czech group experience
Year: 2010, type: Conference abstract
2009
-
Centrosome amplification in plasma cells and B-cells of multiple myeloma
Year: 2009, type: Conference abstract
-
CLINICAL IMPLICATION OF HYPERDIPLOIDY/NON-HYPERDIPLOIDY IN MM PATIENTS TREATED BY NEWER DRUGS
Year: 2009, type: Conference abstract
-
Gain 1q21 vs. Velcade and thalidomide based regimen
Year: 2009, type: Conference abstract